{"id":"https://openalex.org/W7204255186","doi":"https://doi.org/10.3389/fphar.2026.1882440","title":"Transition from drug lag to drug loss in pediatric oncology: a comprehensive evaluation of the Japan-U.S. approval gap","display_name":"Transition from drug lag to drug loss in pediatric oncology: a comprehensive evaluation of the Japan-U.S. approval gap","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-26","ids":{"openalex":"https://openalex.org/W7204255186","doi":"https://doi.org/10.3389/fphar.2026.1882440","pmid":"https://pubmed.ncbi.nlm.nih.gov/42718467","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13553378"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1882440","doi":"https://doi.org/10.3389/fphar.2026.1882440","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1882440","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1882440/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204255186"],"child_works_count":6,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1882440/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148199190","display_name":"Kana Yamada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4400009020","display_name":"Institute of Science Tokyo","ror":"https://ror.org/05dqf9946","country_code":"JP","type":"education","lineage":["https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kana Yamada","raw_affiliation_strings":["Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4400009020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148385026","display_name":"Hiroyuki Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4400009020","display_name":"Institute of Science Tokyo","ror":"https://ror.org/05dqf9946","country_code":"JP","type":"education","lineage":["https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Sato","raw_affiliation_strings":["Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4400009020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041004274","display_name":"Akihiro Hirakawa","orcid":"https://orcid.org/0000-0003-2580-7460","observed_orcids":["https://orcid.org/0000-0003-2580-7460"]},"institutions":[{"id":"https://openalex.org/I4400009020","display_name":"Institute of Science Tokyo","ror":"https://ror.org/05dqf9946","country_code":"JP","type":"education","lineage":["https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Akihiro Hirakawa","raw_affiliation_strings":["Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4400009020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041004274"],"corresponding_institution_ids":["https://openalex.org/I4400009020"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1882440","last_page":"1882440"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.2362000048160553,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-drug-development","display_name":"pediatric drug development","score":0.6779999732971191},{"id":"https://openalex.org/keywords/drug-lag","display_name":"drug lag","score":0.7990000247955322},{"id":"https://openalex.org/keywords/drug-loss","display_name":"drug loss","score":0.878000020980835},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.7950000166893005},{"id":"https://openalex.org/keywords/time-to-approval","display_name":"time to approval","score":0.6179999709129333},{"id":"https://openalex.org/keywords/data-extrapolation","display_name":"data extrapolation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8689000010490417},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.6166999936103821},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5982000231742859},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5855000019073486},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5232999920845032},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.4569999873638153},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.40220001339912415},{"id":"https://openalex.org/C2909143077","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric oncology","level":3,"score":0.3905999958515167},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3889999985694885},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.3822999894618988},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.3781999945640564},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.3635999858379364},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3564999997615814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30300000309944153},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.30090001225471497},{"id":"https://openalex.org/C2777106319","wikidata":"https://www.wikidata.org/wiki/Q362104","display_name":"Institutional review board","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.288100004196167},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2800000011920929},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.27059999108314514},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.26669999957084656},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26420000195503235},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.2624000012874603},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.25619998574256897},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25110000371932983}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1882440","doi":"https://doi.org/10.3389/fphar.2026.1882440","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1882440","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1882440/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13553378","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13553378/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13553378/pdf/fphar-17-1882440.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42718467","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42718467","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:cf68017dbd8e48239846c8acbeffa387","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/cf68017dbd8e48239846c8acbeffa387","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1882440","doi":"https://doi.org/10.3389/fphar.2026.1882440","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1882440","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1882440/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204255186.pdf","grobid_xml":"https://content.openalex.org/works/W7204255186.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2069173387","https://openalex.org/W3087291913","https://openalex.org/W4387472185","https://openalex.org/W4402240423","https://openalex.org/W4409400035","https://openalex.org/W4412543666"],"related_works":["https://openalex.org/W3087291913","https://openalex.org/W4385716840","https://openalex.org/W4360944179","https://openalex.org/W2081666142","https://openalex.org/W2063500683","https://openalex.org/W4403683911","https://openalex.org/W3010103628","https://openalex.org/W4387472185","https://openalex.org/W2995232676","https://openalex.org/W4414750471"],"abstract_inverted_index":{"Introduction:":[0],"Pediatric":[1],"drug":[2,61,65,126,259],"development":[3,121,313],"in":[4,25,32,79,165,189,215,230,253,258,266,282,309],"Japan":[5,166,270,288],"faces":[6],"significant":[7],"challenges":[8],"caused":[9],"by":[10,277],"the":[11,19,33,44,55,84,146,191,210,216,222,233,264,272,310],"case":[12],"rarity":[13],"and":[14,46,63,69,95,119,134,205,218,271,302],"limited":[15,239],"commercial":[16],"incentives.":[17],"Although":[18],"United":[20],"States":[21],"(U.S.)":[22],"RACE":[23],"Act":[24],"2017":[26,172],"has":[27,36],"accelerated":[28],"pediatric":[29,59,76,89,162,187,301],"oncology":[30,60,90],"approvals":[31],"U.S.,":[34],"it":[35],"coincided":[37],"with":[38,75,92,124,153,228],"a":[39],"widening":[40],"approval":[41,77,86,155,159,188,195,214,229,237,252,260],"gap":[42],"between":[43,269],"U.S.":[45,93,217,234,273],"Japan.":[47,80,231,254,283],"This":[48],"retrospective":[49],"observational":[50],"study":[51,235],"aimed":[52],"to":[53,70,101,144,173,194,201,240,250],"clarify":[54],"current":[56],"status":[57,78,87],"of":[58,88,149,161,247],"lag":[62,104],"apparent":[64,125],"loss":[66,127],"through":[67],"2025":[68],"explore":[71],"structural":[72,147],"factors":[73,122,224],"associated":[74,123,152,227],"Methods:":[81],"We":[82],"assessed":[83],"Japanese":[85,117,154,303],"drugs":[91,113,248],"Food":[94],"Drug":[96,103],"Administration":[97],"indications":[98],"from":[99,169,198,315],"2000":[100],"2025.":[102],"was":[105,142,196,238,244],"evaluated":[106],"using":[107,130],"Kaplan-Meier":[108,177],"analysis,":[109],"primarily":[110],"focusing":[111],"on":[112],"that":[114,184,209,295],"successfully":[115],"obtained":[116],"approval,":[118],"clinical":[120,150,312],"were":[128,221],"analyzed":[129],"Fisher's":[131],"exact":[132],"test":[133],"multivariable":[135],"logistic":[136],"regression.":[137],"Decision":[138],"tree":[139],"analysis":[140,178,207],"(CART)":[141],"performed":[143],"identify":[145],"hierarchy":[148],"characteristics":[151],"status.":[156],"Results:":[157],"The":[158],"rate":[160],"drug-indication":[163,182],"pairs":[164,183],"significantly":[167],"declined":[168],"81.8%":[170],"before":[171],"31.8%":[174],"after":[175],"2017.":[176],"suggested":[179],"that,":[180],"among":[181],"ultimately":[185],"achieved":[186],"Japan,":[190],"median":[192],"time":[193],"shortened":[197],"48.9":[199],"months":[200],"21.1":[202],"months.":[203],"Multivariate":[204],"CART":[206],"identified":[208],"trial":[211],"phase":[212],"supporting":[213,236],"sponsor":[219],"type":[220],"key":[223],"most":[225],"strongly":[226],"When":[232],"early-phase":[241],"trials":[242],"or":[243],"absent,":[245],"92.9%":[246],"failed":[249],"achieve":[251],"Discussion:":[255],"While":[256],"delays":[257],"may":[261],"have":[262],"shortened,":[263],"disparity":[265],"therapeutic":[267],"access":[268],"is":[274],"increasingly":[275],"driven":[276],"persistent":[278],"not":[279],"yet":[280],"approved":[281],"To":[284],"address":[285],"this":[286],"gap,":[287],"should":[289],"transition":[290],"toward":[291],"an":[292],"integrated":[293],"strategy":[294],"balances":[296],"robust":[297],"domestic":[298],"bridging-leveraging":[299],"foreign":[300],"adult":[304],"data":[305],"extrapolation-with":[306],"proactive":[307],"participation":[308],"global":[311],"engine":[314],"its":[316],"earliest":[317],"phases.":[318]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204255186","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-08-27T00:00:00"}
